BioMarin Pharmaceutical Inc (BMRN)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 537.54M | 596.42M | 595.28M | 581.33M | 646.21M | 648.83M | 712.03M | 745.74M |
営業利益 | -24.5M | 59.35M | 58.87M | 25.66M | 41.92M | 78.46M | 120.45M | 113.89M |
税引前収入 | -17.56M | 56.76M | 70.81M | 41.67M | 19.33M | 105.55M | 132.14M | 134.44M |
純利益 | -249k | 50.85M | 56.04M | 40.38M | 20.38M | 88.66M | 107.17M | 106.08M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -22.64M | 48.52M | 61.95M | 29.71M | 35.08M | 89.73M | 117.19M | 116.1M |
EBITDA | 53k | 85.77M | 84.29M | 51.35M | 68.78M | 105.81M | 146.92M | 132.9M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.17B | 1.31B | 1.49B | 1.7B | 1.86B | 1.85B | 2.1B | 2.42B |
営業利益 | -803.97M | -135.19M | -174.08M | -126.04M | -96.27M | -20.41M | 41.56M | 185.8M |
税引前収入 | -831.05M | -35.88M | -142.71M | -94.81M | -42.32M | -13.42M | 149.58M | 188.56M |
純利益 | -630.21M | -117.04M | -77.21M | -23.85M | 859.1M | -2.15M | 141.56M | 167.65M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -3.65 | -0.666 | -0.433 | -0.133 | 4.727 | -0.012 | 0.76 | 0.89 |
EBIT | -799.04M | -2.22M | -121.87M | -94.1M | -29.62M | -8.56M | 147.51M | 175.26M |
EBITDA | -101.45M | -23.19M | -53.38M | 16.76M | 57.37M | 87.63M | 143.53M | 290.18M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約